The Application segment of the Cervical Speculum market is defined by the clinical context in which the device is employed, and it drives the majority of revenue generation. Diagnostic applications, encompassing colposcopy, Pap smear collection, and histopathological sampling, represent the largest share, accounting for roughly 45 % of total sales due to the high frequency of routine cervical cancer screening programs worldwide. Therapeutic use, which includes procedures such as cervical biopsies, polypectomy, and hysteroscopic interventions, contributes an estimated 35 % of market volume, reflecting the growing demand for minimally invasive gynecologic treatments. Screening applications, distinct from diagnostic sampling, involve visual inspection with acetic acid (VIA) and other population‑based initiatives, and they comprise about 20 % of the market. Together, these application categories form the core of Cervical Speculum segmentation, shaping product development priorities and influencing the allocation of manufacturing capacity across the sector.